LAVA Medtech Acquisition Corp. Unit
LVACU
LVACU was delisted on the 19th of April, 2023.
39 hedge funds and large institutions have $66.5M invested in LAVA Medtech Acquisition Corp. Unit in 2021 Q4 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
+$6.07M |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$5.06M |
| 3 |
GL
Governors Lane
New York
|
+$4.96M |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$4.07M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$4.05M |
Top Sellers
LVACU Hedge Fund Activity: Q4 2021 in Review
39 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Unit (LVACU) for Q4 2021, worth a combined $66.5M.
Buyers outnumbered sellers: 39 funds opened new LVACU positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Castle Creek Arbitrage, opening a new position worth an estimated $6.07M.
- 39 institutional investors held LAVA Medtech Acquisition Corp. Unit (LVACU) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $66.5M of LAVA Medtech Acquisition Corp. Unit stock for Q4 2021.
- 39 funds opened new LAVA Medtech Acquisition Corp. Unit positions in Q4 2021 and 0 closed out, a net change of +39 holders.
- The largest LAVA Medtech Acquisition Corp. Unit buyer in Q4 2021 was Castle Creek Arbitrage, an estimated $6.07M added.
Based on aggregated 13F filings for Q4 2021.